A detailed history of Qube Research & Technologies LTD transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 30,825 shares of VOR stock, worth $24,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,825
Previous 95,367 67.68%
Holding current value
$24,351
Previous $95,000 77.89%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.1 $45,179 - $70,996
-64,542 Reduced 67.68%
30,825 $21,000
Q2 2024

Aug 14, 2024

BUY
$1.0 - $2.2 $95,367 - $209,807
95,367 New
95,367 $95,000
Q1 2023

May 15, 2023

BUY
$4.68 - $6.96 $158,703 - $236,020
33,911 Added 170.97%
53,745 $289,000
Q4 2022

Feb 14, 2023

BUY
$3.77 - $7.43 $18,850 - $37,150
5,000 Added 33.71%
19,834 $131,000
Q3 2022

Nov 14, 2022

SELL
$3.9 - $5.52 $5,705 - $8,075
-1,463 Reduced 8.98%
14,834 $59,000
Q2 2022

Aug 15, 2022

SELL
$3.89 - $6.44 $82,242 - $136,154
-21,142 Reduced 56.47%
16,297 $81,000
Q1 2022

May 09, 2022

SELL
$6.04 - $12.23 $38,535 - $78,027
-6,380 Reduced 14.56%
37,439 $226,000
Q4 2021

Feb 01, 2022

BUY
$11.32 - $18.02 $337,494 - $537,248
29,814 Added 212.88%
43,819 $509,000
Q3 2021

Nov 12, 2021

BUY
$12.24 - $20.38 $171,421 - $285,421
14,005 New
14,005 $220,000
Q2 2021

Aug 13, 2021

SELL
$18.65 - $38.78 $169,062 - $351,540
-9,065 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$30.96 - $54.08 $280,652 - $490,235
9,065 New
9,065 $391,000

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $30.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.